Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

NDRA ENDRA Life Sciences Inc

5,25

0,25 (5,00%)

Nach Börsenschluss

Zuletzt aktualisiert: 22:00:44

Verzögert um 15 Minuten

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

null

ENDRA Life Sciences (NASDAQ:NDRA)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more ENDRA Life Sciences Charts.

ENDRA Life Sciences (NASDAQ:NDRA)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more ENDRA Life Sciences Charts.

News ENDRA Life Sciences Inc

Form 8-K - Current report
Freitag 22 November 2024 (2 Monate vor) • Edgar (US Regulatory)

ENDRA Life Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement
Freitag 22 November 2024 (2 Monate vor) • Business Wire

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Donnerstag 21 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 19 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 15 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
Freitag 15 November 2024 (2 Monate vor) • Edgar (US Regulatory)

ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update
Freitag 15 November 2024 (2 Monate vor) • Business Wire

Study Highlighting ENDRA Life Sciences’ TAEUS Technology in Patients with High BMI to be Presented at AASLD’s The Liver Meeting® 2024
Dienstag 12 November 2024 (3 Monate vor) • Business Wire

ENDRA Life Sciences Further Strengthens TAEUS® Platform Intellectual Property with Issuance of 17th European Patent
Mittwoch 6 November 2024 (3 Monate vor) • Business Wire

Form 8-K - Current report
Dienstag 5 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 29 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

ENDRA Life Sciences Activates TAEUS System to Initiate Clinical Study at LMU University Hospital in Germany
Dienstag 22 Oktober 2024 (3 Monate vor) • Business Wire

Weitere ENDRA Life Sciences Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen